The world’s biggest gathering of rare disease researchers, patient groups, pharmaceutical executives, and government officials is planned for April 10–12…
Larry Luxner
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Larry Luxner
About 100 scientists, researchers, pharmaceutical executives, and others will converge on Austria’s capital city early next month for the…
Warning the reporter accompanying him not to take any pictures, veteran horticulturalist Michael Castleman punches an electronic code and unlocks…
G71.01 is, literally, the code for Duchenne muscular dystrophy. Â Q93.51 stands for Angelman syndrome, and G40.419 covers generalized…
Shayne Turpin experienced his first seizure at the age of seven months. His parents were told it was a…
Cash-strapped governments across the 28-member European Union are struggling to control runaway healthcare expenditures — at exactly the same time…
#NORDSummit – Major Issues on Table for Rare Disease Patients in US as Midterm Elections Approach
With the U.S. midterm elections now less than two weeks away, patient advocacy groups are solidly focused on a range…
Half a year has gone by since disgraced pharma executive Martin Shkreli was sentenced to seven years in federal prison…
More than 700 medical experts, pharmaceutical executives, patient advocates, and others are expected to converge on Washington, D.C., next month…
As President Trump signed the recently passed Right to Try legislation into law in a White House ceremony, Jordan McLinn…